Aqueous Composition Stabilizes Saliva DNA for Room Temperature Storage

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current DNA amplification methods, such as PCR, face challenges with inhibitors in bodily fluids like saliva, requiring separate extraction steps that are time-consuming and costly, and existing methods for storing DNA are not suitable for ambient temperature storage without refrigeration, limiting the reliability and convenience of using saliva as a DNA source.

Innovation Solution

An aqueous composition that stabilizes nucleic acids in saliva for at least 14 days at room temperature, allowing direct use in nucleic acid amplification reactions without additional processing, comprising chelating agents, denaturing agents, and a pH buffer, which inhibits nucleases and maintains DNA stability.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If separate extraction steps are performed to remove inhibitors from bodily fluids, then DNA amplification reliability is improved, but time consumption and cost increase

Engineering Contradiction:
ImproveDNA amplification reliabilityVSAvoidtime consumption
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent combines the DNA extraction and purification steps with the amplification reaction setup into a single integrated process. The aqueous composition is added directly to the PCR reaction mixture containing the bodily fluid, eliminating the need for separate extraction steps while maintaining amplification reliability through the inclusion of inhibitor-removal components in the same reaction vessel

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The aqueous composition acts as an intermediary substance that mediates between the inhibitory bodily fluid and the sensitive PCR reaction. It contains chelating agents that bind inhibitors and protective agents that shield the amplification reaction from inhibition, allowing direct mixing without prior purification

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If separate extraction steps are performed to remove inhibitors from bodily fluids, then DNA amplification reliability is improved, but cost increases

Engineering Contradiction:
ImproveDNA amplification reliabilityVSAvoidcost
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

The patent combines multiple functions (inhibitor removal, DNA protection, and amplification) into a single aqueous composition that is added directly to the PCR reaction. This eliminates the need for separate extraction reagents, columns, and equipment, reducing overall cost while maintaining reliability

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The aqueous composition serves multiple functions simultaneously: it chelates inhibitors, protects DNA from degradation, and enables direct amplification. This multi-functionality replaces multiple separate extraction and purification steps, reducing both material costs and procedural complexity

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Stability of the object's composition

If refrigeration is used to store DNA samples, then DNA stability is improved, but convenience and accessibility worsen

Engineering Contradiction:
ImproveDNA stabilityVSAvoidconvenience
Core Design Contradiction:
Stability of the object's compositionVSEase of operation

Solution Approach 1:

The patent changes the chemical parameters of the storage environment by using an aqueous composition with specific pH, ionic strength, and protective agents that create conditions allowing DNA stability at ambient temperature. This eliminates the need for refrigeration while maintaining DNA integrity

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The aqueous composition contains self-protective components that automatically maintain DNA stability without external intervention. The chelating agents continuously bind inhibitors and the protective agents continuously shield DNA, providing ongoing stabilization at room temperature without requiring active refrigeration

Inventive Principle:
Principle #25Self-service

4Quantity of substance

If invasive blood collection procedures are used, then DNA quantity is improved, but patient comfort and safety worsen

Engineering Contradiction:
ImproveDNA quantityVSAvoidpatient discomfort
Core Design Contradiction:
Quantity of substanceVSObject-affected harmful factors

Solution Approach 1:

The patent changes the sample type parameter from blood to saliva, which provides sufficient DNA quantity for amplification without the invasive collection procedure. The aqueous composition is optimized to work with saliva's specific chemical parameters, enabling reliable amplification from this less invasive source

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables reliable and efficient DNA amplification from saliva samples stored at room temperature for extended periods, reducing the need for invasive DNA extraction procedures and improving the sensitivity and convenience of DNA-based analyses.

Implementation Method 1

comprising a chelating agent

Methodology Applied
Scientific EffectChelation:

Implementation Method 2

comprising a denaturing agent

Methodology Applied
Scientific EffectDenaturation:

Implementation Method 3

comprising a pH buffer

Methodology Applied
Scientific EffectBuffering:

Data Source

PatentUS8470536B2Compositions and method for storage of nucleic acid from bodily fluids
Publication Date: 2013.06.25 DNA GENOTEK
  • US8470536B2 patent drawing
  • US8470536B2 patent drawing
  • US8470536B2 patent drawing

AI summary

The present invention provides an aqueous composition and method for extracting nucleic acid from a sample of bodily fluid, such as saliva, such that the nucleic acid within said sample remains stable for at least fourteen days at room temperature. The composition permits direct use of the extracted and stored DNA in an amplification reaction without further processing.